Surface modification and endothelialization of vascular biomaterials are common
approaches that are used to both resist the nonspecific adhesion of proteins and improve …

Tissue engineered vascular grafts (TEVGs) are beginning to achieve clinical success and
hold promise as a source of grafting material when donor grafts are unsuitable or …

Rebuilding tissues involves the creation of a vasculature to supply nutrients and this in turn
means that the endothelial cells (ECs) of the resulting endothelium must be a quiescent non …

The ability of the biomimetic peptides YIGSR, PHSRN and RGD to selectively affect
adhesion and migration of human microvascular endothelial cells (MVEC) and vascular …

The higher patency rates of cardiovascular implants, including vascular bypass grafts,
stents, and heart valves are related to their ability to inhibit thrombosis, intimal hyperplasia …

As an urgently needed device for vascular diseases, the small-diameter vascular graft is
limited by high thrombogenicity in clinical applications. Rapid endothelialization is a …

Establishing and maintaining a healthy endothelium on vascular and intravascular devices
is crucial for the prevention of thrombosis and stenosis. Generating a biofunctional surface …

For years intensive research has been done to improve the hemocompatibility of blood
contacting vascular devices. Despite the enormous progress in physicochemical surface …

Although blood-contacting medical devices have been widely used in the biomedical field,
their low endothelialization seriously limits their treatment success. Gene transfection can …

Rapid and controlled vascularization of engineered tissues remains one of the key
limitations in thick tissue engineering. Although many studies have focused on improving the …